PepGen

PEPGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$197.132 M

$2.85 +18.26%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$89.7M

Loss-making

Shares outstanding

69,259,517

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#267NovaBridge BiosciencesNBP$201.9M
#268Minerva NeurosciencesNERV$198.9M
#269PepGenPEPG$197.1M
#270ImmunicIMUX$194.8M
#271Tonix PharmaceuticalsTNXP$191.8M

Where these numbers come from

Share counts and financials for PepGen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.